[Modern approaches to the therapy of biliary system diseases].

The therapeutic efficacy of duspatalin was evaluated in 72 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.

[Insulin edema in patients with diabetes mellitus and recent diabetic ketoacidosis (epidemiology and case reports)]. / Insulinovyi otek u bol'nykh sakharnym diabetom, nedavno perenesshikh diabeticheskii ketoatsidoz (épidemiologicheskie dannye i klinicheskie varianty).

Insulin edema (IE) has been known for a long time as one of complications caused by insulin therapy, but even today its pathogenesis stays unclear, and epidemiology unknown. IE incidence in patients over 15 years of age receiving treatment in the year 2003 for diabetic ketoacidosis (DKA) in the city of Donetsk (adult population 858200) has been retrospectively studied according to clinical archives and national diabetics register data. Presented are three own observations on the development of IE after DKA treatment. 13 (17%) out of 76 DKA patients had IE. Keeping in mind reoccurring DKA incidents--16%. During IE the known duration of Diabetes Mellitus came out to be 5 years on average, and did not differ from insulin therapy duration, whereas the Diabetes Mellitus duration in non DKA group without edemas exceeded the continuance of insulin treatment by over two years (P < 0.05).